Implications of test characteristics and population seroprevalence on 'immune passport' strategies

Clin Infect Dis. 2020 Jul 20;ciaa1019. doi: 10.1093/cid/ciaa1019. Online ahead of print.

Abstract

Various forms of 'immune passports' or 'antibody certificates' are being considered in conversations around reopening economies after periods of social distancing. One critique of such programs focuses on the uncertainty around whether seropositivity means immunity from repeat infection. However, an additional important consideration is that the low positive predictive value of serological tests in the setting of low population seroprevalence and imperfect test specificity will lead to many false-positive 'passport' holders. Here, we pose a simple question: how many false-positive 'passports' could be issued while maintaining herd immunity in the workforce? Answering this question leads to a simple mathematical formula for the minimum requirements of serological tests for a passport program, which depend on population prevalence and the value of R0. Our work replaces speculation in the press with rigorous analysis and will need to be considered in policy decisions that are based on individual and population serology results.

Keywords: COVID-19; SARS-CoV-2; immune passports; positive predictive value; seroprevalence.